Status:
NO_LONGER_AVAILABLE
Expanded Access Program for Participants Who Completed Study 13-601 and Continue to Clinically Benefit From Cerdulatinib
Lead Sponsor:
Alexion Pharmaceuticals, Inc.
Conditions:
Relapsed/Refractory Chronic Lymphocytic Leukemia
Non-hodgkin's Lymphoma
Eligibility:
All Genders
18+ years
Brief Summary
This expanded access program will provide continued access to cerdulatinib to eligible participants who experienced clinical benefit from cerdulatinib in Study 13-601 (NCT01994382) and who otherwise m...
Eligibility Criteria
Inclusion
- Participant has completed Portola Study 13-601 and wishes to continue treatment with cerdulatinib.
- In the opinion of the Investigator, the potential benefit to the participant of continuing to receive cerdulatinib outweighs the risks.
- Female participants of childbearing potential and male participants must agree to continue to abstain from sexual intercourse or to remain on an effective method of contraception during treatment and for 90 days following the last dose of protocol therapy (examples of effective methods of contraception include oral contraceptives or double barrier methods, such as condom plus spermicide or condom plus diaphragm).
- Participant must be willing to give written informed consent and be able to adhere to dose and visit schedules.
Exclusion
- Participant requires chronic treatment with a strong CYP3A4 inhibitor or inducer.
- Participant has a known hypersensitivity to any of the components of cerdulatinib.
- Participant is female and is breast-feeding, pregnant, or intends to become pregnant.
- Participant is participating in any therapeutic clinical study.
Key Trial Info
Start Date :
Trial Type :
EXPANDED_ACCESS
End Date :
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT04757259
Last Update
March 19 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.